Literature DB >> 32930334

Tumor-on-a-chip platform to interrogate the role of macrophages in tumor progression.

Ye Bi1, Venktesh S Shirure2, Ruiyang Liu3,4, Cassandra Cunningham1, Li Ding3,4, J Mark Meacham5, S Peter Goedegebuure1,6, Steven C George2, Ryan C Fields1,6.   

Abstract

Tumor-infiltrating leukocytes, in particular macrophages, play an important role in tumor behavior and clinical outcome. The spectrum of macrophage subtypes ranges from antitumor 'M1'-type to protumor 'M2'-type macrophages. Tumor-associated macrophages (TAMs) typically display phenotypic features of both M1 and M2, and the population distribution is thought to be dynamic and evolves as the tumor progresses. However, our understanding of how TAMs impact the tumor microenvironment remains limited by the lack of appropriate 3D in vitro models that can capture cell-cell dynamics at high spatial and temporal resolution. Using our recently developed microphysiological 'tumor-on-a-chip' (TOC) device, we present here our findings on the impact of defined macrophage subsets on tumor behavior. The TOC device design contains three adjacent and connected chambers in which both the upper and lower chambers are loaded with tumor cells, whereas the central chamber contains a dynamic, perfused, living microvascular network. Introduction of human pancreatic or colorectal cancer cells together with M1-polarized macrophages significantly inhibited tumor growth and tumor-induced angiogenesis. Protein analysis and antibody-based neutralization studies confirmed that these effects were mediated through production of C-X-C motif chemokines (CXCL9), CXCL10 and CXCL11. By contrast, M2-macrophages mediated increased tumor cell migration into the vascularized chamber and did not inhibit tumor growth or angiogenesis. In fact, single-cell RNA sequencing showed that M2 macrophages further segregated endothelial cells into two distinct subsets, corresponding to static cells in vessels versus active cells involved in angiogenesis. The impact of M2 macrophages was mediated mostly by production of matrix metalloproteinase 7 and angiopoietin 2. In summary, our data demonstrate the utility of the TOC device to mechanistically probe biological questions in a 3D in vitro microenvironment.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  angiogenesis; macrophage; tumor invasion; tumor-on-a-chip

Year:  2020        PMID: 32930334      PMCID: PMC7525664          DOI: 10.1093/intbio/zyaa017

Source DB:  PubMed          Journal:  Integr Biol (Camb)        ISSN: 1757-9694            Impact factor:   2.192


  62 in total

1.  Expression of Von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis.

Authors:  L Zanetta; S G Marcus; J Vasile; M Dobryansky; H Cohen; K Eng; P Shamamian; P Mignatti
Journal:  Int J Cancer       Date:  2000-01-15       Impact factor: 7.396

2.  Low levels of physiological interstitial flow eliminate morphogen gradients and guide angiogenesis.

Authors:  Venktesh S Shirure; Andrew Lezia; Arnold Tao; Luis F Alonzo; Steven C George
Journal:  Angiogenesis       Date:  2017-06-12       Impact factor: 9.596

3.  MMP7 expression in colorectal tumours of different stages.

Authors:  Andrea Polistena; Alessandra Cucina; Simona Dinicola; Christina Stene; Giuseppe Cavallaro; Antonio Ciardi; Gennaro Orlando; Rossella Arena; Giuseppe D'Ermo; Antonino Cavallaro; Louis Banka Johnson; Giorgio De Toma
Journal:  In Vivo       Date:  2014 Jan-Feb       Impact factor: 2.155

4.  Integrating single-cell transcriptomic data across different conditions, technologies, and species.

Authors:  Andrew Butler; Paul Hoffman; Peter Smibert; Efthymia Papalexi; Rahul Satija
Journal:  Nat Biotechnol       Date:  2018-04-02       Impact factor: 54.908

Review 5.  Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies.

Authors:  Géraldine Genard; Stéphane Lucas; Carine Michiels
Journal:  Front Immunol       Date:  2017-07-14       Impact factor: 7.561

Review 6.  Macrophages in Colorectal Cancer Liver Metastases.

Authors:  Nina Cortese; Cristiana Soldani; Barbara Franceschini; Marialuisa Barbagallo; Federica Marchesi; Guido Torzilli; Matteo Donadon
Journal:  Cancers (Basel)       Date:  2019-05-07       Impact factor: 6.639

7.  Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma.

Authors:  Xiu-Tao Fu; Kang Song; Jian Zhou; Ying-Hong Shi; Wei-Ren Liu; Guo-Ming Shi; Qiang Gao; Xiao-Ying Wang; Zhen-Bin Ding; Jia Fan
Journal:  Cancer Cell Int       Date:  2019-03-25       Impact factor: 5.722

Review 8.  Diverse Functions of Macrophages in Different Tumor Microenvironments.

Authors:  Ming Yang; Daniel McKay; Jeffrey W Pollard; Claire E Lewis
Journal:  Cancer Res       Date:  2018-09-11       Impact factor: 12.701

9.  Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.

Authors:  Nana O Wilson; Wesley Solomon; Leonard Anderson; John Patrickson; Sidney Pitts; Vincent Bond; Mingli Liu; Jonathan K Stiles
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

Review 10.  Tumor-associated macrophages: an accomplice in solid tumor progression.

Authors:  Yibing Chen; Yucen Song; Wei Du; Longlong Gong; Haocai Chang; Zhengzhi Zou
Journal:  J Biomed Sci       Date:  2019-10-20       Impact factor: 8.410

View more
  6 in total

Review 1.  Engineering microenvironments for manufacturing therapeutic cells.

Authors:  Brian J Kwee; Kyung E Sung
Journal:  Exp Biol Med (Maywood)       Date:  2021-07-11

Review 2.  Development and Application of Endothelial Cells Derived From Pluripotent Stem Cells in Microphysiological Systems Models.

Authors:  Crystal C Kennedy; Erin E Brown; Nadia O Abutaleb; George A Truskey
Journal:  Front Cardiovasc Med       Date:  2021-02-15

Review 3.  Advances in Modeling the Immune Microenvironment of Colorectal Cancer.

Authors:  Paul Sukwoo Yoon; Nuala Del Piccolo; Venktesh S Shirure; Yushuan Peng; Amanda Kirane; Robert J Canter; Ryan C Fields; Steven C George; Sepideh Gholami
Journal:  Front Immunol       Date:  2021-02-10       Impact factor: 7.561

Review 4.  Microfluidic Platforms for High-Throughput Pancreatic Ductal Adenocarcinoma Organoid Culture and Drug Screening.

Authors:  Marlene Geyer; Karla Queiroz
Journal:  Front Cell Dev Biol       Date:  2021-12-23

Review 5.  Tumor treating fields: An emerging treatment modality for thoracic and abdominal cavity cancers.

Authors:  Travis H Jones; Jonathan W Song; Laith Abushahin
Journal:  Transl Oncol       Date:  2021-11-27       Impact factor: 4.243

Review 6.  Engineering strategies to capture the biological and biophysical tumor microenvironment in vitro.

Authors:  Matthew L Tan; Lu Ling; Claudia Fischbach
Journal:  Adv Drug Deliv Rev       Date:  2021-06-28       Impact factor: 17.873

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.